Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

New
New Allied Market Research

Proteomics Market by Component (Instruments, Reagents, and Services) and Application (Drug Discovery, Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2027

A01352
Pages: 221
Jan 2021 | 12319 Views
 
Author(s) : Trupti Wadekar, Smita Nerkar , Onkar Sumant
Tables: 81
Charts: 65
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Proteomics Market

Request Now !

The global proteomics market was valued at $21,122.32 million in 2019, and is projected to reach $49,978.8 million by 2027 at a CAGR of 12.2% from 2020 to 2027. Proteomics is the study of protein structure and function. At the cellular level, proteomics deals with the topics, such as which proteins are expressed, when and where they are expressed, what their structures in both active and inactive states are, what roles they play in the life of the cell, and how they interact with other proteins and molecules.

The COVID-19 outbreak that started from the Wuhan city of China has now widespread globally. Almost every nation is dealing with the outbreak. Most markets are dropping down as COVID-19 outbreak has negatively affected various healthcare related markets. This pandemic is expected to present growth opportunities in the future. The development of therapeutic and preventive strategies requires an accurate understanding of the role that proteins play in the SARS-CoV-2 infection process and progression of COVID-19. A wide array of identification and separation techniques can isolate proteins from complex mixtures, facilitating the analysis of protein-protein interactions, temporal expression patterns, and cellular or subcellular distribution. For instance, most common separation methods are one- and two-dimensional gel electrophoresis and high-performance liquid chromatography, whereas mass spectrometry (MS) forms the backbone of protein detection and identification. Protein identification using MS techniques has overcome the limitations of other proteomic technologies (including 2D gel-electrophoresis) that require a large amount of purified protein for analysis. MS-based viral peptide detection has previously been used to profile viral proteins that affect respiratory pathways. Presently, reverse transcription-polymerase chain reaction (RT-PCR) is the primary method used to detect viral genes in COVID-19-positive patients.

However, the high mutability of SARS-CoV-2 can mean RT-PCR is not sensitive enough to detect these genes. Furthermore, the technique is low throughput owing to its long reaction times. Conversely, MS-based detection, can provide simple and rapid detection of SARS-CoV-2, even among recovered patients. Hence, in the perspective of COVID-19, proteomics can help to reveal novel biomarkers and define point-of-care procedures that could mean cost-effective healthcare can be delivered closer to the patient.

Global-Proteomics-Market,-2020-2027

Get more information on this report : Request Sample Pages

Proteomics market growth is driven by rise in popularity of personalized medicines, surge in R&D expenditure, and technological advancements associated with proteomics components. Moreover, high costs associated with components and dearth of skilled professionals hamper the market growth. Conversely, lucrative opportunities associated with biomarker identification and developments in mass spectrometry-based proteomics are expected to provide lucrative growth opportunities for the proteomics market growth.

The global proteomics market is segmented on the basis of component, application, and region. On the basis of component, the market is categorized into reagents, instruments, and services. The reagents segment is further classified into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is sub segmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry. Similarly, the chromatography segment is sub classified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography. The applications covered in the study include drug discovery, disease diagnosis, and others. Region wise, the proteomics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Component type segment review

Protein microarray segment generated the highest revenue in 2019 in the proteomics instruments market, owing to high usage of this technology to track protein interactions in lesser time as compared to other technologies. Moreover, this method is labor-intensive and cost-effective. With the help of protein array, the comprehensive information about the DNA/RNA binding proteins can be made available. By reagents segment, immunoassays generated the highest revenue in 2019 in the proteomics market, as they are extensively utilized in primary screening in drug discovery and microarray technologies. 

Proteomics Market
By Product

Your browser does not support the canvas element.

Reagents segment held a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Application segment review

On the basis of application, the drug discovery segment accounted for the majority proteomics market share in 2019, owing to increase in awareness of personalized medicines in both emerging and developed markets.

Proteomics Market
By Application

Your browser does not support the canvas element.

Drug Discovery segment held a dominant position in 2019 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Region segment review

North America held the largest market share of nearly 39.0% of the total proteomics market in 2019, due to increase in popularity and adoption of personalized medicines and favorable government funding & initiatives to develop novel therapeutics. However, Asia-Pacific is expected to grow at a CAGR of 15.6% from 2019 to 2027, owing to rise in prevalence of chronic diseases and increase in interest of researchers to utilize proteomics in disease diagnosis & treatment.

Proteomics Market
By Region

2027
North America 
Europe
Asia-pacific
Lamea

North America was holding a dominant position in 2019 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

Some of the key players operating in the proteomics market include Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation. The other players included in the value chain analysis (but not included in the report) are Becton, Dickinson and Company, Caprion Biosciences, and others.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global proteomics market size with current trends and future estimations from 2019 to 2027 to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the proteomics market growth is provided.
  • Identification of factors instrumental in changing the proteomics market size, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
  • A deep dive analysis of various regions provides insights that would allow companies to strategically plan their business moves.
  • Key players are profiled, and their strategies are analysed thoroughly to understand the competitive outlook of the proteomics market.

Key Market Segments

By Component

  • Instruments    
    • Microarray    
    • Spectrometry
      • Mass Spectrometry
      • NMR Spectrometry
    • X-ray Crystallography
    • Chromatography
      • HPLC Systems
      • Ion Chromatography
      • Affinity Chromatography
      • Supercritical Fluid Chromatography
    • Electrophoresis
    • Surface Plasmon Resonance
    • Protein Fractionation Reagents    
  • Reagents
    • Microarray
    • Spectroscopy
    • X-ray Crystallography
    • Chromatography
    • Electrophoresis
    • Immunoassay
    • Protein Fractionation Reagents
  • Services

By Application

  • Drug Discovery
  • Disease Diagnosis
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.1.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top winning strategies
3.2.2.Top investment pockets
3.2.3.Top player positioning

3.3.Porter’s five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Increase in popularity of personalized medicines
3.4.1.2.Increase in R&D expenditure
3.4.1.3.Technological advancements associated with proteomics components

3.4.2.Restraints

3.4.2.1.High costs associated with proteomics components
3.4.2.2.Dearth of skilled professionals

3.4.3.Opportunities

3.4.3.1.Lucrative opportunities associated with biomarker identification
3.4.3.2.Developments in mass spectrometry-based proteomics

3.5.COVID-19 impact analysis for proteomics market

CHAPTER 4:PROTEOMICS MARKET, BY COMPONENT

4.1.Overview

4.1.1.Market size and forecast

4.2.Reagents

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market size and forecast, by component type

4.2.4.Microarray

4.2.4.1.Market size and forecast

4.2.5.Spectrometry

4.2.5.1.Market size and forecast

4.2.6.X-ray crystallography

4.2.6.1.Market size and forecast

4.2.7.Chromatography

4.2.7.1.Market size and forecast

4.2.8.Electrophoresis

4.2.8.1.Market size and forecast

4.2.9.Immunoassay

4.2.9.1.Market size and forecast

4.2.10.Protein fractionation reagents

4.2.10.1.Market size and forecast

4.2.11.Market analysis, by country

4.3.Instruments

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Microarray

4.3.3.1.Market size and forecast

4.3.4.Spectrometry

4.3.4.1.Market size and forecast
4.3.4.2.Market size and forecast

4.3.4.2.1.Mass spectrometry

4.3.4.2.1.1.Market size and forecast

4.3.4.2.2.NMR spectrometry

4.3.4.2.2.1.Market size and forecast

4.3.5.Chromatography

4.3.5.1.Market size and forecast
4.3.5.2.Market size and forecast

4.3.5.2.1.HPLC systems

4.3.5.2.1.1.Market size and forecast

4.3.5.2.2.Ion chromatography

4.3.5.2.2.1.Market size and forecast

4.3.5.2.3.Affinity chromatography

4.3.5.2.3.1.Market size and forecast

4.3.5.2.4.Supercritical fluid chromatography

4.3.5.2.4.1.Market size and forecast

4.3.6.Electrophoresis

4.3.6.1.Market size and forecast

4.3.7.Surface plasmon resonance

4.3.7.1.Market size and forecast

4.3.8.X-ray crystallography

4.3.8.1.Market size and forecast

4.3.9.Protein fractionation systems

4.3.9.1.Market size and forecast

4.3.10.Market analysis, by country

4.4.Services

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

CHAPTER 5:PROTEOMICS MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Drug discovery

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Disease diagnosis

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Others

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

CHAPTER 6:PROTEOMICS MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by country

6.2.2.1.U.S.

6.2.2.1.1.U.S. proteomics market, by component
6.2.2.1.2.U.S. proteomics market, by application

6.2.2.2.Canada

6.2.2.2.1.Canada proteomics market, by component
6.2.2.2.2.Canada proteomics market, by application

6.2.2.3.Mexico

6.2.2.3.1.Mexico proteomics market, by component
6.2.2.3.2.Mexico proteomics market, by application

6.2.3.North America proteomics market, by component
6.2.4.North America proteomics market, by application

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country

6.3.2.1.Germany

6.3.2.1.1.Germany proteomics market, by component
6.3.2.1.2.Germany proteomics market, by application

6.3.2.2.France

6.3.2.2.1.France proteomics market, by component
6.3.2.2.2.France proteomics market, by application

6.3.2.3.UK

6.3.2.3.1.UK proteomics market, by component
6.3.2.3.2.UK proteomics market, by application

6.3.2.4.Italy

6.3.2.4.1.Italy proteomics market, by component
6.3.2.4.2.Italy proteomics market, by application

6.3.2.5.Spain

6.3.2.5.1.Spain proteomics market, by component
6.3.2.5.2.Spain proteomics market, by application

6.3.2.6.Rest of Europe

6.3.2.6.1.Rest of Europe proteomics market, by component
6.3.2.6.2.Rest of Europe proteomics market, by application

6.3.3.Europe proteomics market, by component
6.3.4.Europe proteomics market, by application

6.4.Asia-Pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by country

6.4.2.1.Japan

6.4.2.1.1.Japan proteomics market, by component
6.4.2.1.2.Japan proteomics market, by application

6.4.2.2.China

6.4.2.2.1.China proteomics market, by component
6.4.2.2.2.China proteomics market, by application

6.4.2.3.India

6.4.2.3.1.India proteomics market, by component
6.4.2.3.2.India proteomics market, by application

6.4.2.4.Australia

6.4.2.4.1.Australia proteomics market, by component
6.4.2.4.2.Australia proteomics market, by application

6.4.2.5.South Korea

6.4.2.5.1.South Korea proteomics market, by component
6.4.2.5.2.South Korea proteomics market, by application

6.4.2.6.Rest of Asia-Pacific

6.4.2.6.1.Rest of Asia-Pacific proteomics market, by component
6.4.2.6.2.Rest of Asia-Pacific proteomics market, by application

6.4.3.Asia-Pacific proteomics market, by component
6.4.4.Asia-Pacific proteomics market, by application

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by country

6.5.2.1.Brazil

6.5.2.1.1.Brazil proteomics market, by component
6.5.2.1.2.Brazil proteomics market, by application

6.5.2.2.Saudi Arabia

6.5.2.2.1.Saudi Arabia proteomics market, by component
6.5.2.2.2.Saudi Arabia proteomics market, by application

6.5.2.3.South Africa

6.5.2.3.1.South Africa proteomics market, by component
6.5.2.3.2.South Africa proteomics market, by application

6.5.2.4.Rest of LAMEA

6.5.2.4.1.Rest of LAMEA proteomics market, by component
6.5.2.4.2.Rest of LAMEA proteomics market, by application

6.5.3.LAMEA proteomics market, by component
6.5.4.LAMEA proteomics market, by application

CHAPTER 7:COMPANY PROFILES

7.1.AGILENT TECHNOLOGIES INC.

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments

7.2.BIO-RAD LABORATORIES, INC.

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments

7.3.BRUKER CORPORATION

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product type portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments

7.4.DANHER CORPORATION.

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments

7.5.GE HEALTHCARE

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product Portfolio
7.5.5.Business performance

7.6.HORIBA, LTD.

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance

7.7.LI-COR, INC.

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio

7.8.PERKINELMER INC.

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product Portfolio
7.8.5.Business performance

7.9.THERMO FISHER SCIENTIFIC, INC.

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments

7.10.WATERS CORPORATION

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product type portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL PROTEOMICS REAGENTS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 02.PROTEOMICS REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.PROTEOMICS REAGENTS MARKET, BY COMPONENT TYPE, 2019–2027 ($MILLION)
TABLE 04.PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 05.PROTEOMICS INSTRUMENTS MARKET, BY COMPONENT TYPE, 2019–2027 ($MILLION)
TABLE 06.PROTEOMICS INSTRUMENTS MARKET FOR SPECTROMETRY, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.PROTEOMICS INSTRUMENTS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2019–2027 ($MILLION)
TABLE 08.PROTEOMICS SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 10.PROTEOMICS MARKET FOR DRUG DISCOVERY, BY REGION, 2019–2027 ($MILLION)
TABLE 11.PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 12.PROTEOMICS MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 01.PROTEOMICS MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)
TABLE 02.NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 03.U.S. PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 04.U.S. PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 05.CANADA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 06.CANADA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 07.MEXICO PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 08.MEXICO PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 09.NORTH AMERICA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 10.NORTH AMERICA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 11.EUROPE PROTEOMICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 12.GERMANY PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 13.GERMANY PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 14.FRANCE PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 15.FRANCE PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 16.UK PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 17.UK PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 18.ITALY PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 19.ITALY PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 20.SPAIN PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 21.SPAIN PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 22.REST OF EUROPE PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 23.REST OF EUROPE PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 24.EUROPE PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 25.EUROPE PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 26.ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 27.JAPAN PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 28.JAPAN PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 29.CHINA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 30.CHINA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 31.INDIA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 32.INDIA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 33.AUSTRALIA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 34.AUSTRALIA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 35.SOUTH KOREA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 36.SOUTH KOREA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 37.REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 38.REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 39.ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 40.ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 41.LAMEA PROTEOMICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 42.BRAZIL PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 43.BRAZIL PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 44.SAUDI ARABIA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 45.SAUDI ARABIA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 46.SOUTH AFRICA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 47.SOUTH AFRICA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 48.REST OF LAMEA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 49.REST OF LAMEA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 50.LAMEA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 51.LAMEA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 52.AGILENT: COMPANY SNAPSHOT
TABLE 53.AGILENT: OPERATING SEGMENTS
TABLE 54.AGILENT: PRODUCT PORTFOLIO
TABLE 55.BIO-RAD: COMPANY SNAPSHOT
TABLE 56.BIO-RAD: OERATING SEGMENT
TABLE 57.BIO-RAD: PRODUCT PORTFOLIO
TABLE 58.BRUKER: COMPANY SNAPSHOT
TABLE 59.BRUKER: OPERATING SEGMENTS
TABLE 60.BRUKER: PRODUCT TYPE PORTFOLIO
TABLE 61.DANAHER: COMPANY SNAPSHOT
TABLE 62.DANAHER: OPERATING SEGMENTS
TABLE 63.DANAHER: PRODUCT PORTFOLIO
TABLE 64.GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 65.GE HEALTHCARE: OPERATING SEGMENTS
TABLE 66.GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 67.HORIBA: COMPANY SNAPSHOT
TABLE 68.HORIBA: BUSINESS SEGMENTS
TABLE 69.HORIBA: PRODUCT PORTFOLIO
TABLE 70.LI-COR, INC.: COMPANY SNAPSHOT
TABLE 71.LI-COR, INC.: OPERATING SEGMENTS
TABLE 72.LI-COR, INC.: PRODUCT PORTFOLIO
TABLE 73.PERKINELMER: COMPANY SNAPSHOT
TABLE 74.PERKINELMER: OPERATING SEGMENTS
TABLE 75.PERKINELMER: PRODUCT PORTFOLIO
TABLE 76.THERMO FISHER SCIENTIFIC.: COMPANY SNAPSHOT
TABLE 77.THERMO FISHER SCIENTIFIC: PRODUCT SEGMENTS
TABLE 78.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 79.WATERS: COMPANY SNAPSHOT
TABLE 80.WATERS: OPERATING SEGMENTS
TABLE 81.WATERS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.GLOBAL PROTEOMICS MARKET SEGMENTATION
FIGURE 02.TOP WINNING STRATEGIES, 2017–2020
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020
FIGURE 05.TOP INVESTMENT POCKETS
FIGURE 06.TOP PLAYER POSITIONING, 2019
FIGURE 07.HIGH BARGAINING POWER OF BUYERS
FIGURE 08.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE THREAT OF SUBSTITUTION
FIGURE 11.HIGH COMPETITIVE RIVALRY
FIGURE 12.DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13.PROTEOMICS REAGENTS MARKET FOR MICROARRAY, 2019–2027 ($MILLION)
FIGURE 14.PROTEOMICS REAGENTS MARKET FOR SPECTROMETRY, 2019–2027 ($MILLION)
FIGURE 15.PROTEOMICS REAGENTS MARKET FOR X-RAY CRYSTALLOGRAPHY, 2019–2027 ($MILLION)
FIGURE 16.PROTEOMICS REAGENTS MARKET FOR CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 17.PROTEOMICS REAGENTS MARKET FOR ELECTROPHORESIS, 2019–2027 ($MILLION)
FIGURE 18.PROTEOMICS REAGENTS MARKET FOR IMMUNOASSAY, 2019–2027 ($MILLION)
FIGURE 19.PROTEOMICS REAGENTS MARKET FOR PROTEIN FRACTIONATION REAGENTS, 2019–2027 ($MILLION)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF PROTEOMICS REAGENTS MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 21.PROTEOMICS INSTRUMENTS MARKET FOR MICROARRAY, 2019–2027 ($MILLION)
FIGURE 22.PROTEOMICS INSTRUMENTS MARKET FOR SPECTROMETRY, 2019–2027 ($MILLION)
FIGURE 23.PROTEOMICS INSTRUMENTS MARKET FOR MASS SPECTROMETRY, 2019–2027 ($MILLION)
FIGURE 24.NMR SPECTROMETRY PROTEOMICS INSTRUMENTS MARKET, 2019–2027 ($MILLION)
FIGURE 25.PROTEOMICS INSTRUMENTS MARKET FOR CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 26.PROTEOMICS INSTRUMENTS MARKET FOR HPLC SYSTEMS, 2019–2027 ($MILLION)
FIGURE 27.PROTEOMICS INSTRUMENTS MARKET FOR ION CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 28.PROTEOMICS INSTRUMENTS MARKET FOR AFFINITY CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 29.PROTEOMICS INSTRUMENTS MARKET FOR SUPERFICIAL FLUID CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 30.PROTEOMICS INSTRUMENTS MARKET FOR ELECTROPHORESIS, 2019–2027 ($MILLION)
FIGURE 31.PROTEOMICS INSTRUMENTS MARKET FOR SURFACE PLASMON RESONANCE, 2019–2027 ($MILLION)
FIGURE 32.PROTEOMICS INSTRUMENTS MARKET FOR X-RAY CRYSTALLOGRAPHY, 2019–2027 ($MILLION)
FIGURE 33.PROTEOMICS INSTRUMENTS MARKET FOR PROTEIN FRACTIONATION SYSTEMS, 2019–2027 ($MILLION)
FIGURE 34.COMPARATIVE SHARE ANALYSIS OF PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 35.COMPARATIVE SHARE ANALYSIS OF PROTEOMICS SERVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 36.COMPARATIVE ANALYSIS OF PROTEOMICS MARKET, FOR DRUG DISCOVERY BY COUNTRY, 2019–2027 (%)
FIGURE 37.COMPARATIVE ANALYSIS OF PROTEOMICS MARKET, FOR DISEASE DIAGNOSIS BY COUNTRY, 2019–2027 (%)
FIGURE 38.COMPARATIVE ANALYSIS OF PROTEOMICS MARKET, FOR OTHERS BY COUNTRY, 2019–2027 (%)
FIGURE 39.AGILENT: NET SALES, 2017–2019 ($MILLION)
FIGURE 40.AGILENT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 41.AGILENT: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 42.BIO-RAD: NET SALES, 2017–2019 ($MILLION)
FIGURE 43.BIO-RAD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 44.BIO-RAD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 45.BRUKER: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.BRUKER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 47.BRUKER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 48.DANAHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.DANAHER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 50.DANAHER: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 51.GE HEALTHCARE: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 53.GE HEALTHCARE: REVENUE SHARE BY REGION, 2019(%)
FIGURE 54.HORIBA: NET SALES, 2017–2019 ($MILLION)
FIGURE 55.HORIBA: NET SALES, BY SEGMENT, 2019 (%)
FIGURE 56.HORIBA: NET SALES, BY REGION, 2019 (%)
FIGURE 57.PERKINELMER: NET SALES, 2015–2017 ($MILLION)
FIGURE 58.PERKINELMER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 59.PERKINELMER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 60.THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 61.THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENTS, 2019 (%)
FIGURE 62.THERMO FISHER SCIENTIFIC. REVENUE SHARE BY REGION, 2019 (%)
FIGURE 63.WATERS: NET SALES, 2017–2019 ($MILLION)
FIGURE 64.WATERS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 65.WATERS: REVENUE SHARE BY REGION, 2019 (%)

 
 

The global proteomics market is expected to witness significant growth in the future. The market has piqued the interest of the healthcare industry, as proteomics helps to bridge the gap between the understanding of genome expression and cellular behavior as well as aids in increasing the popularity of personalized medicines. Moreover, the need for personalized medicines is anticipated to increase considerably, which will fuel the growth of the global market. The use of proteomics is the highest in the North American region, followed by Europe and Asia-Pacific, owing to heavy R&D expenditure and increased research funding from various organizations, such as National Institutes of Health (NIH).

Moreover, North America is expected to remain dominant during the forecast. In addition, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to the key players during the forecast period, due to increase in disposable income of populace, improvement in healthcare infrastructure, and rise in demand for advanced technologies, such as proteomics.
 

 
PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Proteomics Market is $21,122.32 million in 2019

A. The forecast period in the report is from 2020 to 2027

A. The market value of Proteomics Market in 2020 was $22,303.06 Million

A. The base year for the report is 2019

A. Yes, Proteomics companies are profiled in the report

A. The top companies that hold the market share in Proteomics Market are Thermo Fisher Scientific, Bruker Corporation Inc., Agilent Technologies Inc., Waters Corporation, and PerkinElmer, Inc.

A. No, there is no value chain analysis provided in the Proteomics Market report

A. The key trends in the Proteomics Market are increase in popularity of personalized medicines and advances in proteomic technologies

Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research

RELATED TAGS

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Proteomics Market

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers